Grayscale Ethereum Staking ETF (Ticker: ETHE) Becomes First U.S. Ethereum ETP to Distribute Staking Rewards

Grayscale Ethereum Staking ETF (Ticker: ETHE) Becomes First U.S. Ethereum ETP to Distribute Staking Rewards Shares of Grayscale Ethereum Staking ETF set to trade ex-Dividend at Today's Market Open GlobeNewswire January 05, 2026 STAMFORD, Conn., Jan. 05, 2026 (GLOBE NEWSWIRE) — Grayscale, the world's largest digital asset-focused investment platform*, today announced that Grayscale Ethereum Staking […]

Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference

Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 05, 2026 CAMBRIDGE, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President

The Oncology Institute Announces Addition of Board Member Mark Stolper

The Oncology Institute Announces Addition of Board Member Mark Stolper GlobeNewswire January 05, 2026 CERRITOS, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) — The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Mark Stolper has joined the Board of Directors, effective January 2, 2026.

Corvus Pharmaceuticals Confirms Plans to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis in January 2026 Following Annual Healthcare Conference

Corvus Pharmaceuticals Confirms Plans to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis in January 2026 Following Annual Healthcare Conference GlobeNewswire January 05, 2026 SOUTH SAN FRANCISCO, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, confirms the planned announcement

Casella Waste Systems, Inc. completes CEO transition: President Ned Coletta assumes CEO role

Casella Waste Systems, Inc. completes CEO transition: President Ned Coletta assumes CEO role GlobeNewswire January 05, 2026 RUTLAND, Vt., Jan. 05, 2026 (GLOBE NEWSWIRE) — Casella Waste Systems, Inc. (NASDAQ: CWST), a regional solid waste, recycling and resource management services company, today announced the successful completion of its CEO succession plan. Edmond R. “Ned” Coletta

DeFi Development Corp. Partners with Hylo to Boost Yield and Participate in Points Program

DeFi Development Corp. Partners with Hylo to Boost Yield and Participate in Points Program GlobeNewswire January 05, 2026 BOCA RATON, FL, Jan. 05, 2026 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced a partnership with Hylo,

Off The Hook Yachts’ Autograph Yacht Group Achieves Substantial Q4 2025 Momentum in Luxury Yacht Sales

Off The Hook Yachts' Autograph Yacht Group Achieves Substantial Q4 2025 Momentum in Luxury Yacht Sales GlobeNewswire January 05, 2026 New luxury brokerage secures ~$100 million in listings and closes 22 deals worth ~$35 million since October launch Off The Hook's comprehensive platform integrates premium brokerage and wholesale trade-ins driven by industry-leading AI engine with

Reliance Global Group Authorizes the Formation of EZRA International Group, a New Division Focused on Accelerating Breakthrough Technology Companies

Reliance Global Group Authorizes the Formation of EZRA International Group, a New Division Focused on Accelerating Breakthrough Technology Companies GlobeNewswire January 05, 2026 LAKEWOOD, NJ, Jan. 05, 2026 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: RELI) (the “Company”) today announced the unanimous Board approval for its formation of EZRA International Group, a new division

Medera Announces Completion of Patient Enrollment in Cohort B of MUSIC-HFpEF Phase 1/2a Clinical Trial

Medera Announces Completion of Patient Enrollment in Cohort B of MUSIC-HFpEF Phase 1/2a Clinical Trial GlobeNewswire January 05, 2026 BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) — Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, today announced that the final patient has been dosed in Cohort B (high-dose

rYojbaba Issues Letter to Shareholders Detailing 2025 Operational Highlights and 2026 Strategic Priorities

rYojbaba Issues Letter to Shareholders Detailing 2025 Operational Highlights and 2026 Strategic Priorities GlobeNewswire January 05, 2026 FUKUOKA, Japan, Jan. 05, 2026 (GLOBE NEWSWIRE) — rYojbaba Co., Ltd. (Nasdaq: RYOJ) (“rYojbaba” or the “Company”), a Japanese labor consulting and health services company, today issued a letter to its shareholders addressing recent operational highlights and future

Scroll to Top